Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole vs Amphotericin B for Fungal Infection
NCT00002277Phase 3Completed
- Sponsor
- Pfizer
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised trial of fluconazole in mycosis (2 arms), sponsored by Pfizer. Primary endpoints: Safety and Tolerance and Efficacy. Status: completed.
02
Drugs
fluconazole
03
Conditions
mycosis
Beyond the preview
Go deeper on NCT00002277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002277.